alzheimer disease research News
-
Alfa Chemistry Launches Donepezil for Alzheimer's Disease Research
Alfa Chemistry, a long-term partner for many pharmaceutical companies, universities, and research institutions, recently announced to offer donepezil, a synthetic active pharmaceutical ingredient (API) that can be used in pharmaceutical preparation for the treatment of Alzheimer's disease. API refers to the biologically active component of a drug product. In recent decades, the great importance ...
-
Lilly`s donanemab slowed Alzheimer`s disease progression in Phase 2 trial: full data presented at AD/PD™ 2021 and published in NEJM
Phase 2 TRAILBLAZER-ALZ results presented today by Eli Lilly and Company (NYSE: LLY) at the 15th International Conference on Alzheimer's & Parkinson Diseases™ 2021 (AD/PD™ 2021) held virtually March 9-14, 2021 and published simultaneously in the New England Journal of Medicine (NEJM) expand on previously reported top-line data that found donanemab met its primary endpoint and ...
-
Metlife foundation announces major awards to scientists for research in alzheimer`s disease
The 25th anniversary presentation of the MetLife Foundation Awards for Medical Research in Alzheimer's Disease (AD) was held today honoring two noted researchers, Randy L. Buckner, Ph.D., professor of Psychology and of Neuroscience at Harvard University and Howard Hughes Medical Institute Investigator, and Marcus E. Raichle, M.D., professor of radiology and neurology at Washington University ...
-
Research from Beacon Biosignals Presented at Alzheimer`s Association International Conference
Beacon Biosignals, a startup that applies AI to EEG to unlock precision medicine for neurological and psychiatric disorders, presented research at the Alzheimer's Association International Conference, which took place July 31–Aug. 4, 2022, in San Diego. Medical Director Jay Pathmanathan, MD, PhD, discussed how the company has applied its machine learning platform to standard ...
-
NIH investigators discover new mechanism that may be important for learning and memory
New findings in mice suggest that the timing when the neurotransmitter acetylcholine is released in the brain's hippocampus may play a key role in regulating the strength of nerve cell connections, called synapses. Understanding the complex nature of neuronal signaling at synapses could lead to better understanding of learning and memory, and novel treatments for relevant disorders, such as ...
-
NIH investigators discover new mechanism that may be important for learning and memory
New findings in mice suggest that the timing when the neurotransmitter acetylcholine is released in the brain's hippocampus may play a key role in regulating the strength of nerve cell connections, called synapses. Understanding the complex nature of neuronal signaling at synapses could lead to better understanding of learning and memory, and novel treatments for relevant disorders, such as ...
-
DiamiR Receives Award from Alzheimer`s Drug Discovery Foundation to Accelerate Development of microRNA Biomarkers for Alzheimer`s Disease
DiamiR, a developer of innovative blood-based diagnostic tests for neurodegenerative and other diseases, announced today a $492,000 award in support of the project entitled "Circulating brain-enriched microRNAs as peripheral biomarkers of neurodegeneration." The award will accelerate the development of DiamiR's targeted diagnostic technology for detection and prediction of Alzheimer's disease ...
By DiamiR
-
Veravas and Tymora Collaborate on Early Detection Alzheimer’s Testing
CHARLESTON,S.C. and OAKDALE, Minn., January, 13 2020, - Veravas, Inc. and Tymora Analytical Operations, LLC announced today that they have entered into a strategic alliance to explore the integration of their respective technologies. Veravas is an emerging diagnostic company focused on proprietary sample preparation products and new diagnostic tests. Tymora’s focus is on providing ...
-
Two Research Studies Bolster Method That C2N’s PrecivityAD Blood Test Uses to Aid Clinicians in Alzheimer’s Disease Diagnoses
Two recent studies demonstrated that the scientific method that serves as the basis for C2N Diagnostics’ PrecivityAD™ blood test scored best compared to others assays in their respective ability to identify amyloid plaque. The C2N Diagnostics PrecivityAD™ blood test that clinicians use to aid in diagnosing Alzheimer’s disease is underpinned by the liquid ...
-
DiamiR Announces Oral Presentation at 21st International Conference on Alzheimer`s Drug Discovery
DiamiR, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, today announced that Dr. Kira Sheinerman, Chief Executive Officer, will be presenting and participating in a panel discussion at The 21st International Conference on Alzheimer's Drug Discovery hosted by the Alzheimer's Drug Discovery Foundation (ADDF) and held virtually October 5-6, ...
By DiamiR
-
A night at Sardi`s announces 2011 Honoree
The 19th Annual "A Night at Sardi's," a star-studded benefit for the Alzheimer's Association on Wednesday, March 16, 2011 at the Beverly Hilton, will honor The Walt Disney Company's President and CEO Robert A. Iger for his contributions in the fight against Alzheimer's disease. Mr. Iger will receive the Abe Burrows Entertainment Award, which is presented to an individual who has shown an ...
-
PERKINELMER HOSTS FT-IR BIOMEDICAL IMAGING MEDIA ROUNDTABLE
Event Brings Together Experts from Rutgers University, Hunter College and Brookhaven National Laboratory to Discuss Emerging Application of FT-IR Technology in Disease Research ( NEWARK , N.J. ) – PerkinElmer Inc. (NYSE: PKI ), a leading provider of drug discovery, life science research, and analytical solutions, today brought together leading researchers from academia and industry to ...
-
Untargeted Lipidomics Now Available with Creative Proteomics’s New Cutting-Edge Lipidomics Platform
As a division of Creative Proteomics, Lipidomics is dedicated to providing cutting-edge mass spectrometry (MS)-based lipidomics services for biomedical research institutions, biotechnology companies, and pharmaceutical companies. The company has recently announced the fully-developed untargeted lipidomics service, which can analyze hundreds of different lipids simultaneously, and is widely used ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you